A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT06644118 · RECRUITING

Trial details

NCT number: NCT06644118
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-10-23
Primary completion: 2027-10-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.